Fresenius Kabi AG

Company Snapshot

Founded: 1999
Entity Type: Private
Employees: 41,000
Region: Germany
Revenue: $9,105.7 Millions
Revenue Year: 2024
Headquarter: Bad Homburg , Germany
Key Geographics: Europe, North America, Latin America, Asia-Pacific, Africa
Corporate Address: Else-Kröner-Straße 1 ​ 61352 Bad Homburg Germany Tel. ​​​​​+49-6172-686-0 www.fresenius-kabi.com

Company Overview

Fresenius Kabi is one of four business segments of Fresenius SE & Co. KGaA, a European diversified healthcare company based in Bad Homburg, Germany. The Fresenius Group offers products and services for dialysis, hospitals, and inpatient and outpatient medical care. The company’s product offerings cater to various therapeutic areas, including oncology, diabetes, maldigestion, critical care, liver and renal insufficiency, pediatrics, and blood volume substitution. Fresenius is developing biosimilar products in the areas of immunology and oncology.

Financial Highlights (FY 2024)

Net Revenue: ***
Operating Income: ***

This information is available for BCC Research members only.

Fresenius Kabi AG In Reports

Cell Therapy Processing: Global Markets and Technologies

BCC Research detailed report on cell therapy processing market includes global revenue ($ Million) for the base year data of 2024 and estimated data for the forecast period 2025 through 2030.

Biosimilars: Global Markets

BCC Research Report: Dive into biosimilars market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, and forecast for 2029.

Global Markets for Generic Drugs

BCC Research Market Analyst says global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a CAGR of 8.5%.

Company's Business Segments

  • Pharma : Pharma segment includes Life-Saving Medicines, IV Therapy, Infusion Therapy, Injectable Drugs.
  • MedTech : Medical Technologies For Nutrition, Infusion, Cell Therapies, Blood Collection.
  • Nutrition : We offer optimal solutions for both Enteral Nutrition, Prenteral Nutrition that meet the highest quality standards so that healthcare professionals can make the right medical nutrition decision according to the Patient’s Individual Needs, Medical Diagnosis, Treatment Goals.
  • Biopharma : An end-to-end offering in Autoimmune Diseases, Oncology.

Applications/End User Industries

  • Hospitals
  • Healthcare Professionals
  • Oncology
  • Long-Term Care Facilities
  • Clinics
  • Nephrology
  • Pediatrics
  • Geriatrics
  • Surgery
  • Enteral Nutrition
  • Parenteral Nutrition
  • Ambulatory
  • Analgesia
  • Anesthetics
  • Critical Care Drugs
  • Alternate Care Sites
  • Research Labs
  • Blood And Plasma Collection Centers
AI Sentiment